ctrl K

Price Alert

aTyr Pharma Inc. (ATYR)

NASDAQ: ATYR · Real-Time Price · USD

4.90

-0.09 (-1.80%)

At close: Aug 15, 2025, 3:59 PM

4.93

0.61%

After-hours: Aug 15, 2025, 07:48 PM EDT

aTyr Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.05M	22.54M	9.98M	2.34M
Short-Term Investments	61.07M	75.62M	56.16M	105.58M
Long-Term Investments	n/a	3.48M	3.17M	n/a
Other Long-Term Assets	3.02M	131K	193K	158K
Receivables	1.74M	2.44M	11.78M	435K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	81.95M	102.99M	80.87M	113.57M
Property-Plant & Equipment	11.86M	14.05M	11.56M	1.81M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.88M	17.66M	14.91M	1.97M
Total Assets	96.83M	120.65M	95.79M	115.54M
Account Payables	4.32M	3.53M	3.11M	1.03M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1.25M	1.33M	894K	980K
Other Current Liabilities	5.05M	-1.33M	-894K	-980K
Total Current Liabilities	14.97M	16.42M	13.86M	6.01M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	12.03M	13.77M	10.64M	398K
Total Liabilities	27M	30.18M	24.5M	6.41M
Total Debt	13.28M	15.1M	11.53M	1.38M
Common Stock	84K	63K	29K	28K
Retained Earnings	-532.05M	-468.02M	-417.63M	-372.3M
Comprehensive Income	-40K	-74K	-433K	-263K
Shareholders Equity	70.02M	90.66M	71.46M	109.3M
Total Investments	61.07M	79.11M	59.33M	105.58M